Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
Main Authors: | Shao-bin Wang, Yosuke Nagasaka, Dionne Argyle, Ayami Nagasaka, Praveen Yerramothu, Bradley D. Gelfand, Jayakrishna Ambati |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-02-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-022-01277-4 |
Similar Items
-
Discovery of novel mRNA demethylase FTO inhibitors against esophageal cancer
by: Bo Qin, et al.
Published: (2022-12-01) -
The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging
by: Zhong-xin Jiang, et al.
Published: (2021-07-01) -
Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis
by: Yan-Hong Cui, et al.
Published: (2021-04-01) -
Survey of commercial antibodies targeting Y chromosome‐encoded genes
by: Bradley D. Gelfand, et al.
Published: (2023-12-01) -
Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation
by: Hannah Petraitis Kuschman, et al.
Published: (2023-11-01)